407 related articles for article (PubMed ID: 24758141)
21. Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy.
Xiao B; Si X; Zhang M; Merlin D
Colloids Surf B Biointerfaces; 2015 Nov; 135():379-385. PubMed ID: 26275840
[TBL] [Abstract][Full Text] [Related]
22. Development and characterization of anti-inflammatory activity of curcumin-loaded biodegradable microspheres with potential use in intestinal inflammatory disorders.
Blanco-García E; Otero-Espinar FJ; Blanco-Méndez J; Leiro-Vidal JM; Luzardo-Álvarez A
Int J Pharm; 2017 Feb; 518(1-2):86-104. PubMed ID: 28040561
[TBL] [Abstract][Full Text] [Related]
23. N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin.
Chen H; Wu J; Sun M; Guo C; Yu A; Cao F; Zhao L; Tan Q; Zhai G
J Liposome Res; 2012 Jun; 22(2):100-9. PubMed ID: 22007962
[TBL] [Abstract][Full Text] [Related]
24. Eudragit® S100 coated calcium pectinate microspheres of curcumin for colon targeting.
Zhang L; Cao F; Ding B; Li Q; Xi Y; Zhai G
J Microencapsul; 2011; 28(7):659-67. PubMed ID: 21824069
[TBL] [Abstract][Full Text] [Related]
25. Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles.
Mladenovska K; Raicki RS; Janevik EI; Ristoski T; Pavlova MJ; Kavrakovski Z; Dodov MG; Goracinova K
Int J Pharm; 2007 Sep; 342(1-2):124-36. PubMed ID: 17590293
[TBL] [Abstract][Full Text] [Related]
26. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres.
Rawat M; Saraf S; Saraf S
AAPS PharmSciTech; 2007 Dec; 8(4):E116. PubMed ID: 18181537
[TBL] [Abstract][Full Text] [Related]
27. Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis.
Wang QS; Wang GF; Zhou J; Gao LN; Cui YL
Int J Pharm; 2016 Dec; 515(1-2):176-185. PubMed ID: 27713029
[TBL] [Abstract][Full Text] [Related]
28. Soluble curcumin amalgamated chitosan microspheres augmented drug delivery and cytotoxicity in colon cancer cells: In vitro and in vivo study.
Jyoti K; Bhatia RK; Martis EAF; Coutinho EC; Jain UK; Chandra R; Madan J
Colloids Surf B Biointerfaces; 2016 Dec; 148():674-683. PubMed ID: 27701049
[TBL] [Abstract][Full Text] [Related]
29. An efficient enzyme-triggered controlled release system for colon-targeted oral delivery to combat dextran sodium sulfate (DSS)-induced colitis in mice.
Li S; Jin M; Wu Y; Jung S; Li D; He N; Lee MS
Drug Deliv; 2021 Dec; 28(1):1120-1131. PubMed ID: 34121560
[TBL] [Abstract][Full Text] [Related]
30. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
[TBL] [Abstract][Full Text] [Related]
31. pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres.
Quan JS; Jiang HL; Kim EM; Jeong HJ; Choi YJ; Guo DD; Yoo MK; Lee HG; Cho CS
Int J Pharm; 2008 Jul; 359(1-2):205-10. PubMed ID: 18490120
[TBL] [Abstract][Full Text] [Related]
32. Eudragit coating of chitosan-prednisolone conjugate microspheres and in vitro evaluation of coated microspheres.
Onishi H; Oosegi T; Machida Y; McGinity JW
Drug Dev Ind Pharm; 2007 Aug; 33(8):848-54. PubMed ID: 17729102
[TBL] [Abstract][Full Text] [Related]
33. Curcumin-piperine mixtures in self-microemulsifying drug delivery system for ulcerative colitis therapy.
Li Q; Zhai W; Jiang Q; Huang R; Liu L; Dai J; Gong W; Du S; Wu Q
Int J Pharm; 2015 Jul; 490(1-2):22-31. PubMed ID: 25957703
[TBL] [Abstract][Full Text] [Related]
34. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies.
Anitha A; Sreeranganathan M; Chennazhi KP; Lakshmanan VK; Jayakumar R
Eur J Pharm Biopharm; 2014 Sep; 88(1):238-51. PubMed ID: 24815764
[TBL] [Abstract][Full Text] [Related]
35. Colon targeted bioadhesive pellets of curcumin and cyclosporine for improved management of inflammatory bowel disease.
Desai N; Momin M
Drug Deliv Transl Res; 2020 Oct; 10(5):1288-1301. PubMed ID: 32277353
[TBL] [Abstract][Full Text] [Related]
36. Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan/alginate/Eudragit S multilayers for the treatment of inflammatory bowel disease.
Oshi MA; Naeem M; Bae J; Kim J; Lee J; Hasan N; Kim W; Im E; Jung Y; Yoo JW
Carbohydr Polym; 2018 Oct; 198():434-442. PubMed ID: 30093020
[TBL] [Abstract][Full Text] [Related]
37. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease.
Beloqui A; Coco R; Memvanga PB; Ucakar B; des Rieux A; Préat V
Int J Pharm; 2014 Oct; 473(1-2):203-12. PubMed ID: 25014369
[TBL] [Abstract][Full Text] [Related]
38. Facile preparation of pH-sensitive chitosan microspheres for delivery of curcumin; characterization, drug release kinetics and evaluation of anticancer activity.
Pooresmaeil M; Namazi H
Int J Biol Macromol; 2020 Nov; 162():501-511. PubMed ID: 32574741
[TBL] [Abstract][Full Text] [Related]
39. Novel self-nanomicellizing solid dispersion based on rebaudioside A: a potential nanoplatform for oral delivery of curcumin.
Hou Y; Wang H; Zhang F; Sun F; Xin M; Li M; Li J; Wu X
Int J Nanomedicine; 2019; 14():557-571. PubMed ID: 30666114
[TBL] [Abstract][Full Text] [Related]
40. Chitosan microspheres of aceclofenac: in vitro and in vivo evaluation.
Nagda C; Chotai N; Patel S; Nagda D; Patel U; Soni T
Pharm Dev Technol; 2010; 15(5):442-51. PubMed ID: 20735299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
